The blood and bone marrow cancer treatment market is set to reach from US$ 38.8 Bn in 2018 to US$ 74.9 Bn by 2027 at a compound annual growth rate (CAGR) of 7.7% during the forecast period from 2019 to 2027. As per the research findings brought forward by Janssen Pharmaceutica N.V. approximately 900,000 people throughout the globe are diagnosed with blood cancer annually, it holds a share of 7% of all types of known cancer.
The solid tumor cancer treatment market is set to reach from US$ 121.3 Bn in 2018 to US$ 424.6 Bn by 2027 at a compound annual growth rate (CAGR) of 15.0% during the forecast period from 2019 to 2027. According to the latest statistics presented by the World Health Organization (WHO) in 2018, approximately 9.6 million people are estimated to die due to cancer; they also claim that 30 to 50% of cancer can be prevented with early diagnosis and effective treatment regimen.
The cell expansion market is set to reach from US$ 12,666.8 Mn in 2020 to US$ 49,997.5 Mn by 2033 at a compound annual growth rate (CAGR) of 15.0% during the forecast period from 2025 to 2033. Lack of effective treatment regime for the chronic disease has resulted in significant rise in novel drug discovery and development research studies throughout the globe. Increasing demand for regenerative medicine and stem cell therapy further consolidates the cell expansion market growth.
The global AI-based medical diagnostic tools market is increasing proficiently, expected to grow at a CAGR of 25.6%. Internationally, the increasing prevalence of lifestyle diseases along with huge patient population has suggestively enhanced the growth of artificial intelligence in the healthcare industry. New FDA approvals of AI systems along with enhanced & integrated algorithms, and promising pipeline devices in the medical diagnostics industry are key factors driving the overall growth of AI-based medical diagnostic tools market globally.
The anaplastic lymphoma kinase (ALK) inhibitors market is set to reach from US$ 2,130.8 Mn in 2020 to 16,889.4 Mn by 2033 keen to demonstrate exuberating growth at a compounded annual growth rate (CAGR) of 21.2% during the forecast period from 2025 to 2033. Lung cancer is the second most occurring type of cancer in both men and women population worldwide. Increased consumption of tobacco, unhealthy lifestyle and stress are the major risk factor responsible for the occurrence of lung cancer.
The mobile cancer screening devices market is expected to highlighting positive growth at a compounded annual growth rate (CAGR) of 5.6% during the forecast period from 2025 to 2033. The mobile cancer screening devices are well equipped with efficient ergonomic features and are less expensive in comparison to conventional screening devices. Rising prevalence of cancer worldwide and increasing demand for portable screening devices among oncologist consolidates the market growth for mobile cancer screening devices.
The intravascular catheters market is set to reach US$ 8,051.7 Mn by 2027 from US$ 4,034.7 Mn in 2018 showcasing balanced growth at a compounded annual growth rate (CAGR) of 8.0% during the forecast period from 2019 to 2027. The major drivers associated with the intravascular catheters market growth are significant rise in inpatient surgical procedures in hospitals for treatment of chronic illness and increasing demand for catheters in minimal invasive surgical procedures conducted in catheterization labs & ambulatory care centers.
The bone marrow transplantation market is set growth at a compound annual growth rate (CAGR) of 5.9% during the forecast period from 2025 to 2033. According to the research findings provided by Bristol-Myers Squibb Company, by 2040 there will be 1.85 million new cases of blood cancer will be reported worldwide.
The generic oncology drugs market is set to growth at a compounded annual growth rate (CAGR) of 6.1% during the forecast period from 2025 to 2033. According to the statistics provided by World Health Organization (WHO) in 2025, 9.6 million people worldwide have been estimated to be dead due to cancer. It is considered as the second leading cause of death, researchers are of the opinion that approximately 30% cancer deaths can be prevented by avoiding risk factors such as alcohol consumption, tobacco smoking, early diagnosis etc.
The medical image analysis software market is set to grow from US$ 2,318.4 Mn in 2017 to 4,642.1 Mn in 2026 expanding at a compounded annual growth rate of 8.1% during the forecast period from 2018 to 2026. The drivers associated with medical image analysis software market are rising prevalence of chronic diseases, increasing application of computer aided diagnostic methods and increasing healthcare expenditure in emerging economies.
The oncology drugs market is a critical segment of the pharmaceutical industry, providing innovative solutions for the treatment of cancer. The market is driven by the increasing prevalence of cancer worldwide, advancements in technology, and the emergence of personalized medicine. The oncology drugs market is a highly competitive and dynamic market, with many companies focusing on the development of novel therapies to treat cancer. One of the primary drivers of the oncology drugs market is the increasing prevalence of cancer worldwide. According to the World Health Organization (WHO), cancer is one of the leading causes of death globally, accounting for approximately 9.6 million deaths in 2018. The rising incidence of cancer has led to an increased demand for innovative oncology drugs, driving the growth of the market.
The global oncology drugs market is expected to grow at a CAGR of 13% during the period of 2023 to 2031. The increasing demand for new therapies, coupled with advancements in technology and an increasing focus on personalized medicine, is expected to drive the growth of the market in the coming years. One of the emerging trends in the oncology drugs market is the increasing use of immunotherapy. Immunotherapy involves the use of drugs that stimulate the body's immune system to attack cancer cells. Immunotherapy has shown promising results in the treatment of several types of cancer, including melanoma, lung cancer, and bladder cancer. The development of immunotherapies requires the use of advanced drug discovery technologies and clinical trial design, which has contributed to the growth of the oncology drugs market. Another trend in the oncology drugs market is the increasing focus on precision medicine. Precision medicine involves tailoring medical treatments to individual patients based on their unique genetic and molecular profiles. The development of precision medicine requires the use of advanced diagnostic tools and drug discovery technologies, which have contributed to the growth of the oncology drugs market.
The increasing focus on targeted therapies is also driving the growth of the oncology drugs market. Targeted therapies are drugs that are designed to target specific molecules that are involved in the growth and spread of cancer cells. Targeted therapies can be more effective than traditional chemotherapy, as they have fewer side effects and are more specific in their action. The development of targeted therapies requires the use of advanced drug discovery technologies, which has contributed to the growth of the oncology drugs market.
The increasing use of combination therapies is driving the growth of the oncology drugs market. Combination therapies involve the use of two or more drugs to treat cancer. Combination therapies can improve patient outcomes by targeting multiple pathways involved in the disease process. The development of combination therapies requires the use of advanced drug discovery technologies and clinical trial design, which has contributed to the growth of the oncology drugs market. The oncology drugs market is a critical segment of the pharmaceutical industry, providing innovative solutions for the treatment of cancer. The increasing prevalence of cancer worldwide, advancements in technology, and emerging trends in immunotherapy, precision medicine, targeted therapies, and combination therapies are expected to drive the growth of the oncology drugs market. As the demand for new and effective therapies continues to increase, the oncology drugs market is expected to remain a critical component of the pharmaceutical industry in the coming years. Companies that provide oncology drugs and related services are well-positioned to capitalize on this growing market.
